A 38-year-old woman from rural Maharashtra presents to the gynaecology clinic for routine screening. She is married at age 18, has 3 children, and reports no abnormal vaginal discharge or postcoital bleeding. Her last menstrual period was 2 weeks ago. On speculum examination, the cervix appears normal. Pap smear is performed and the report shows "Atypical Squamous Cells of Undetermined Significance (ASCUS)." HPV testing is positive for high-risk HPV-16. What is the most appropriate next step in management?

Explanation

## Clinical Context ASCUS with positive high-risk HPV (HPV-16) represents an intermediate-risk lesion that requires further evaluation to exclude cervical intraepithelial neoplasia (CIN) or invasive disease. ## Management Algorithm for ASCUS + HPV-Positive ```mermaid flowchart TD A[ASCUS on Pap smear]:::outcome --> B{HPV testing}:::decision B -->|HPV negative| C[Routine screening in 3 years]:::action B -->|HPV positive| D[Colposcopy with directed biopsy]:::action D --> E{Biopsy result}:::decision E -->|No CIN| F[Routine screening]:::action E -->|CIN 1| G[Observation or excision]:::action E -->|CIN 2/3| H[Excisional treatment]:::urgent ``` ## Key Decision Points **Key Point:** ASCUS + HPV-positive requires colposcopy because the risk of underlying CIN 2/3 is approximately 20–30%, which is unacceptably high to manage conservatively. **High-Yield:** The 2012 ASCCP (American Society for Colposcopy and Cervical Pathology) guidelines and Indian cervical cancer screening protocols recommend: - **ASCUS + HPV-negative** → routine screening in 3 years - **ASCUS + HPV-positive** → immediate colposcopy - **ASCUS + HPV unknown** → repeat cytology in 12 months OR reflex HPV testing **Clinical Pearl:** HPV-16 is one of the most oncogenic high-risk types; its presence in the setting of ASCUS substantially elevates the pre-test probability of CIN. ## Why Colposcopy? Colposcopy allows direct visualization of the cervix under magnification, identification of acetowhite lesions, and targeted tissue sampling to determine the grade of dysplasia (if any) and guide definitive treatment. ## Citation [cite:ASCCP Guidelines 2012; Obstetric and Gynaecological Society of India Cervical Cancer Screening Guidelines]